Miao Chenggui, Chang Jun
Department of Pharmacology, College of Integrated Chinese and Western Medicine, Anhui University of Chinese Medicine, 1 Qianjiang Road, Xinzhan District, Hefei, 230012, Anhui Province, China.
Institute of Integrated Chinese and Western Medicine, Anhui Academy of Chinese Medicine, Hefei, 230012, China.
J Mol Med (Berl). 2021 May;99(5):619-636. doi: 10.1007/s00109-021-02052-8. Epub 2021 Feb 27.
MicroRNAs (miRNAs) are non-encoding, single-stranded RNA molecules of about 22 nucleotides in length encoded by endogenous genes involved in posttranscriptional gene expression regulation. Studies have shown that miRNAs participate in a series of important pathophysiological processes, including the pathogenesis of depression. This article systematically summarized the research results published in the field of miRNAs and depression, which mainly involved three topics: circulating miRNAs as markers for diagnosis and prognosis of depression, the regulatory roles of miRNAs in the pathogenesis of depression, and the roles of miRNAs in the mechanisms of depression treatment. By summarizing and analyzing the research literature in recent years, we found that some circulating miRNAs can be potential biomarkers for the diagnosis and prognostic evaluation of depression. miRNAs that disorderly expressed during the disease play important roles in the depression pathogenesis, and miRNAs also play roles in the mechanisms of psychotherapy and drug therapy for depression. Elucidating the important roles of miRNAs in depression will bring people's understanding of the pathogenesis of depression to a new level. In addition, these miRNAs may be developed as new biomarkers for diagnosing depression, or as drug targets, or these molecules may be used as new drugs, which may provide new means for the treatment of depression. KEY MESSAGES: • The research results of miRNAs and depression are reviewed. • Circulating miRNAs can be potential biomarkers for depression. • MiRNAs play important roles in the depression pathogenesis. • MiRNAs play important roles in drug therapy for depression.
微小RNA(miRNA)是一类非编码的单链RNA分子,长度约为22个核苷酸,由参与转录后基因表达调控的内源基因编码。研究表明,miRNA参与了一系列重要的病理生理过程,包括抑郁症的发病机制。本文系统总结了miRNA与抑郁症领域发表的研究成果,主要涉及三个主题:循环miRNA作为抑郁症诊断和预后的标志物、miRNA在抑郁症发病机制中的调控作用以及miRNA在抑郁症治疗机制中的作用。通过总结和分析近年来的研究文献,我们发现一些循环miRNA可能是抑郁症诊断和预后评估的潜在生物标志物。疾病期间异常表达的miRNA在抑郁症发病机制中起重要作用,miRNA在抑郁症的心理治疗和药物治疗机制中也发挥作用。阐明miRNA在抑郁症中的重要作用将使人们对抑郁症发病机制的认识提升到一个新水平。此外,这些miRNA可能被开发为诊断抑郁症的新生物标志物,或作为药物靶点,或者这些分子可能被用作新药,这可能为抑郁症的治疗提供新手段。关键信息:• 综述了miRNA与抑郁症的研究成果。• 循环miRNA可能是抑郁症的潜在生物标志物。• miRNA在抑郁症发病机制中起重要作用。• miRNA在抑郁症药物治疗中起重要作用。